AQS Share Price Performance
CA$0.005
-0.01 (-66.67%)
Price CA$0.005
Share PriceCA$0.005
Aequus Pharmaceuticals Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
AQS Community Narratives
There are no narratives available yet.
There are no community narratives available.
Snowflake Analysis
Aequus Pharmaceuticals Inc. Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
- -0.016
- 57.21%
- -284.96%
- -84.8%
About AQS
- Founded
- 2013
- Employees
- n/a
- CEO
- WebsiteView website
Aequus Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. The company offers ZIMED PF, a preservative-free bimatoprost prescription drug for the for the reduction of elevated interocular pressure in patients with open angle glaucoma or ocular hypertension. It also develops REV-0100, which is in pre-clinical trial for the treatment of stargardt disease. Aequus Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in Vancouver, Canada.
